The Impact of Immunostimulating Nutrition on the Outcome of Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

December 31, 2005

Conditions
Gastric CancerPancreatic Cancer
Interventions
DRUG

peptisorb

standard isocaloric eteral diet (1 ml = 1 kcal)

DRUG

Stresson

Oligopeptic, enteral diet (1 ml=1.25 kcal)

DRUG

Parenteral nutrition

Protein requirements were covered by 10 and 15% amino acid solutions (Aminoplasmal, B Braun, Poland). Energy requirements were covered by glucose (10, 20 and 40% solutions, B Braun, Poland) and lipid emulsions (10 and 20% Lipofundin MCT/ LCT, B Braun, Poland). Addtional: Tracutil, Addamel

DRUG

Omegaven, Dipeptiven

Immunostimulating components: Omegaven (omega-3-fatty acids) and Dipeptiven (Glutamine Arginine) Protein requirements were covered by 10 and 15% amino acid solutions (Aminoplasmal, B Braun, Poland). Energy requirements were covered by glucose (10, 20 and 40% solutions, B Braun, Poland) and lipid emulsions (10 and 20% Lipofundin MCT/ LCT, B Braun, Poland). Addtional: Tracutil, Addamel

Trial Locations (1)

30-798

1st Department of General Surgery, Krakow

All Listed Sponsors
lead

Jagiellonian University

OTHER

NCT00558155 - The Impact of Immunostimulating Nutrition on the Outcome of Surgery | Biotech Hunter | Biotech Hunter